Scripta Insights Planning for Massive Growth in 2023, Building on its Proven Ability to Empower Smarter P

Launches New & Improved Member App, the Ultimate Rx Comparison Shopping Tool,Introduces Precision Couponing

Closes Series A Funding, Cements Strategic Partnerships with Industry Heavy HittersSingleCare, RxMapper, and Lightbeam

BOSTON, Jan. 25, 2023 /PRNewswire/ -- Scripta Insights, a healthcare IT and data analytics company focused on lowering prescription drug costs, is giving self-insured employers, health plans and their members the information and tools they need in 2023 to make smarter buying decisions around Rx benefits and prescriptions. This starts with the launch of a new and improved member app and health benefit that provides unprecedented transparency into drug pricing on the member's health plan, giving patients and their doctors more cost-effective treatment options to consider, without compromising efficacy.

"With record-high inflation squeezing companies and consumers, there is a need, now more than ever, for smart solutions that empower the burgeoning healthcare consumerism movement in the U.S.," said Eric Levin, CEO, Scripta Insights. "At Scripta, we're putting the patient in the driver's seat when it comes to making decisions about the medicines they take like never before, allowing Americans to shop as intelligently and economically for prescription drugs as they can for most other items they buy."